Antiretroviral therapy coverage for PMTCT in IDA total
IDA total: Antiretroviral therapy coverage for PMTCT was 84.5% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in IDA total, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in IDA total stood at 84.5%.
The figure is up 0.1% on the previous year and up 10.5% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in IDA total peaked at 87.0% in 2019 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in IDA total, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.1% | — |
| 2002 | 0.6% | +924.3% |
| 2003 | 2.5% | +293.7% |
| 2004 | 5.7% | +130.7% |
| 2005 | 13.3% | +132.9% |
| 2006 | 21.4% | +60.6% |
| 2007 | 34.9% | +63.0% |
| 2008 | 46.4% | +32.9% |
| 2009 | 53.4% | +15.2% |
| 2010 | 37.6% | -29.6% |
| 2011 | 53.6% | +42.4% |
| 2012 | 66.9% | +24.9% |
| 2013 | 71.4% | +6.7% |
| 2014 | 76.5% | +7.1% |
| 2015 | 79.8% | +4.3% |
| 2016 | 80.2% | +0.5% |
| 2017 | 83.1% | +3.7% |
| 2018 | 85.6% | +3.0% |
| 2019 | 87.0% | +1.7% |
| 2020 | 85.4% | -1.9% |
| 2021 | 84.5% | -1.1% |
| 2022 | 82.4% | -2.4% |
| 2023 | 84.5% | +2.5% |
| 2024 | 84.5% | +0.1% |
Biggest year-on-year movements
Years where Antiretroviral therapy coverage for PMTCT in IDA total changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2002 | +924.3% | 0.1% | 0.6% |
| 2003 | +293.7% | 0.6% | 2.5% |
| 2005 | +132.9% | 5.7% | 13.3% |
| 2004 | +130.7% | 2.5% | 5.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 17.8% | 0.0% | 53.4% | 10 |
| 2010s | 72.2% | 37.6% | 87.0% | 10 |
| 2020s | 84.2% | 82.4% | 85.4% | 5 |
Countries ranked near IDA total
More health data for IDA total
- Population ages 0-14, total, per capita 0.3761 units per person (2025)
- Population, male, per capita 0.4993 units per person (2025)
- Population ages 15-64, male, per capita 0.2904 units per person (2025)
- Population ages 15-64, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 15-64, male, annual growth rate 2.6 % change on previous year (2025)
- Population ages 15-64, female, per capita 0.2939 units per person (2025)
- Population ages 15-64, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population, male 49.9% (2025)
- Population ages 15-64, female, annual growth rate 2.54 % change on previous year (2025)
- Population ages 0-14, male, per capita 0.191 units per person (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in IDA total?
- Antiretroviral therapy coverage for pmtct in IDA total was 84.5% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in IDA total?
- The highest recorded value was 87.0% in 2019.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in IDA total?
- The lowest recorded value was 0.0% in 2000.
- How does IDA total rank for antiretroviral therapy coverage for pmtct?
- IDA total ranks 8th out of 15 groups with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in IDA total?
- Over the last ten years it is up 10.5%. The long-run trend across the full record is volatile.
- Where does this IDA total data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).